Does Dr. RITA AGARWAL have financial conflicts of interest?

Dr. RITA AGARWAL (MD) has received a total of $296 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $296 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RITA AGARWAL?

According to CMS Open Payments data, Dr. RITA AGARWAL received funding from VERTEX PHARMACEUTICALS INCORPORATED ($122), CHIESI USA ($121), and ACACIA PHARMA ($54).

Does Dr. RITA AGARWAL receive research grants or speaking fees?

Dr. RITA AGARWAL has received $296 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RITA AGARWAL

MDReal-Time Hydrated

Specialty: Anesthesiology, Pediatric Anesthesiology

Practice Location: PALO ALTO, CA 94304

NPI Number: 1437264793

LIFETIME INDUSTRY VALUE

$296

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AGARWAL is a verified Anesthesiology, Pediatric Anesthesiology practitioner based in PALO ALTO, CA.

Between 2021 and 2025, Dr. AGARWAL had an overall industry promotional and research financial footprint of $296 as recorded in the federal CMS Open Payments database.

$296 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGARWAL's primary funding source is VERTEX PHARMACEUTICALS INCORPORATED, which accounts for $122 (representing 41.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

VERTEX PHARMACEUTICALS INCORPORATED

Rank 1

$122

41.1%

CHIESI USA

Rank 2

$121

40.7%

ACACIA PHARMA

Rank 3

$54

18.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.